These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 27258093)

  • 1. Analysis of Risk Alleles and Complement Activation Levels in Familial and Non-Familial Age-Related Macular Degeneration.
    Saksens NT; Lechanteur YT; Verbakel SK; Groenewoud JM; Daha MR; Schick T; Fauser S; Boon CJ; Hoyng CB; den Hollander AI
    PLoS One; 2016; 11(6):e0144367. PubMed ID: 27258093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration.
    Smailhodzic D; Klaver CC; Klevering BJ; Boon CJ; Groenewoud JM; Kirchhof B; Daha MR; den Hollander AI; Hoyng CB
    Ophthalmology; 2012 Feb; 119(2):339-46. PubMed ID: 22133792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the common genetic associations of age-related macular degeneration upon systemic complement component C3d levels.
    Ristau T; Paun C; Ersoy L; Hahn M; Lechanteur Y; Hoyng C; de Jong EK; Daha MR; Kirchhof B; den Hollander AI; Fauser S
    PLoS One; 2014; 9(3):e93459. PubMed ID: 24675670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CFH haplotypes and ARMS2, C2, C3, and CFB alleles show association with susceptibility to age-related macular degeneration in Mexicans.
    Contreras AV; Zenteno JC; Fernández-López JC; Rodríguez-Corona U; Falfán-Valencia R; Sebastian L; Morales F; Ochoa-Contreras D; Carnevale A; Silva-Zolezzi I
    Mol Vis; 2014; 20():105-16. PubMed ID: 24453474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zinc supplementation inhibits complement activation in age-related macular degeneration.
    Smailhodzic D; van Asten F; Blom AM; Mohlin FC; den Hollander AI; van de Ven JP; van Huet RA; Groenewoud JM; Tian Y; Berendschot TT; Lechanteur YT; Fauser S; de Bruijn C; Daha MR; van der Wilt GJ; Hoyng CB; Klevering BJ
    PLoS One; 2014; 9(11):e112682. PubMed ID: 25393287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes.
    Reynolds R; Hartnett ME; Atkinson JP; Giclas PC; Rosner B; Seddon JM
    Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5818-27. PubMed ID: 19661236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-Wide Association Study Reveals Variants in CFH and CFHR4 Associated with Systemic Complement Activation: Implications in Age-Related Macular Degeneration.
    Lorés-Motta L; Paun CC; Corominas J; Pauper M; Geerlings MJ; Altay L; Schick T; Daha MR; Fauser S; Hoyng CB; den Hollander AI; de Jong EK
    Ophthalmology; 2018 Jul; 125(7):1064-1074. PubMed ID: 29398083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association analysis of genetic and environmental risk factors in the cuticular drusen subtype of age-related macular degeneration.
    van de Ven JP; Smailhodzic D; Boon CJ; Fauser S; Groenewoud JM; Chong NV; Hoyng CB; Klevering BJ; den Hollander AI
    Mol Vis; 2012; 18():2271-8. PubMed ID: 22933840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rare Genetic Variants Associated With Development of Age-Related Macular Degeneration.
    Saksens NT; Geerlings MJ; Bakker B; Schick T; Daha MR; Fauser S; Boon CJ; de Jong EK; Hoyng CB; den Hollander AI
    JAMA Ophthalmol; 2016 Mar; 134(3):287-93. PubMed ID: 26767664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related macular degeneration and coronary heart disease: evaluation of genetic and environmental associations.
    Keilhauer CN; Fritsche LG; Guthoff R; Haubitz I; Weber BH
    Eur J Med Genet; 2013 Feb; 56(2):72-9. PubMed ID: 23103884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Functional Effect of Rare Variants in Complement Genes on C3b Degradation in Patients With Age-Related Macular Degeneration.
    Geerlings MJ; Kremlitzka M; Bakker B; Nilsson SC; Saksens NT; Lechanteur YT; Pauper M; Corominas J; Fauser S; Hoyng CB; Blom AM; de Jong EK; den Hollander AI
    JAMA Ophthalmol; 2017 Jan; 135(1):39-46. PubMed ID: 27918759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Variants and Systemic Complement Activation Levels Are Associated With Serum Lipoprotein Levels in Age-Related Macular Degeneration.
    Paun CC; Ersoy L; Schick T; Groenewoud JM; Lechanteur YT; Fauser S; Hoyng CB; de Jong EK; den Hollander AI
    Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):7766-73. PubMed ID: 26641553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss.
    Francis PJ; Hamon SC; Ott J; Weleber RG; Klein ML
    J Med Genet; 2009 May; 46(5):300-7. PubMed ID: 19015224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement Activation Levels Are Related to Disease Stage in AMD.
    Heesterbeek TJ; Lechanteur YTE; Lorés-Motta L; Schick T; Daha MR; Altay L; Liakopoulos S; Smailhodzic D; den Hollander AI; Hoyng CB; de Jong EK; Klevering BJ
    Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):18. PubMed ID: 32176267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and environmental risk factors for age-related macular degeneration in persons 90 years and older.
    Ersoy L; Ristau T; Hahn M; Karlstetter M; Langmann T; Dröge K; Caramoy A; den Hollander AI; Fauser S
    Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1842-7. PubMed ID: 24576882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of candidate genes for age-related macular degeneration subtypes in the Japanese population.
    Tanaka K; Nakayama T; Yuzawa M; Wang Z; Kawamura A; Mori R; Nakashizuka H; Sato N; Mizutani Y
    Mol Vis; 2011; 17():2751-8. PubMed ID: 22065928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of polymorphisms in complement component 3 with age-related macular degeneration in an Iranian population.
    Bonyadi M; Mohammadian T; Jabbarpoor Bonyadi MH; Fotouhi N; Soheilian M; Javadzadeh A; Moein H; Yaseri M
    Ophthalmic Genet; 2017; 38(1):61-66. PubMed ID: 27029644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical validation of a genetic model to estimate the risk of developing choroidal neovascular age-related macular degeneration.
    Hageman GS; Gehrs K; Lejnine S; Bansal AT; Deangelis MM; Guymer RH; Baird PN; Allikmets R; Deciu C; Oeth P; Perlee LT
    Hum Genomics; 2011 Jul; 5(5):420-40. PubMed ID: 21807600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of variants in the complement factor H, the elongation of very long chain fatty acids-like 4 and the hemicentin 1 genes of age-related macular degeneration in the Finnish population.
    Seitsonen S; Lemmelä S; Holopainen J; Tommila P; Ranta P; Kotamies A; Moilanen J; Palosaari T; Kaarniranta K; Meri S; Immonen I; Järvelä I
    Mol Vis; 2006 Jul; 12():796-801. PubMed ID: 16885922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and environmental risk factors for extramacular drusen.
    Altay L; Subiras X; Lorés de Motta L; Schick T; Berghold A; Hoyng CB; den Hollander AI; Fauser S; Sadda SR; Liakopoulos S
    Mol Vis; 2020; 26():661-669. PubMed ID: 33088170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.